P&G Merger Talks May Herald Next Step In Consumer-Focused Rx Marketing
Executive Summary
Procter & Gamble's aborted merger discussions with Warner-Lambert and American Home Products may herald the next phase in the evolution of consumer-focused pharmaceutical marketing.
You may also be interested in...
Aventis Sees “Blurring” Of Rx/OTC Distinctions; Change Coming For Allegra?
The antihistamine market can no longer comfortably be divided between prescription and OTC entrants, Aventis Chief Operating Officer Richard Markham suggested during the J.P. Morgan health care conference in San Francisco Jan. 13
Aventis Sees “Blurring” Of Rx/OTC Distinctions; Change Coming For Allegra?
The antihistamine market can no longer comfortably be divided between prescription and OTC entrants, Aventis Chief Operating Officer Richard Markham suggested during the J.P. Morgan health care conference in San Francisco Jan. 13
P&G Actonel Payment Postponed: $50 Mil. Delay Contributes To $40 Bil. Drop
The delay in the approval of Procter & Gamble's Actonel for osteoporosis contributed to the company's $38.7 bil. drop in value following the March 7 announcement that it will miss its earnings targets.